Bank of New York Mellon’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Hold
24,006
﹤0.01% 4271
2026
Q1
$16.6K Buy
+24,006
New +$17.7K ﹤0.01% 4180
2025
Q2
Sell
-200,304
Closed -$114K 4267
2025
Q1
$114K Sell
200,304
-542
-0.3% -$535 ﹤0.01% 3985
2024
Q4
$287K Sell
200,846
-1,198
-0.6% -$2.69K ﹤0.01% 3804
2024
Q3
$390K Sell
202,044
-35,553
-15% -$100K ﹤0.01% 3635
2024
Q2
$737K Buy
237,597
+26,103
+12% +$108K ﹤0.01% 3359
2024
Q1
$1.11M Buy
211,494
+53
+0% +$254 ﹤0.01% 3100
2023
Q4
$685K Buy
211,441
+7,677
+4% +$16.6K ﹤0.01% 3383
2023
Q3
$520K Buy
203,764
+2,650
+1% +$11.1K ﹤0.01% 3525
2023
Q2
$1.18M Buy
201,114
+73,174
+57% +$425K ﹤0.01% 3105
2023
Q1
$365K Buy
127,940
+52,000
+68% +$146K ﹤0.01% 3656
2022
Q4
$153K Hold
75,940
﹤0.01% 4046
2022
Q3
$220K Buy
75,940
+7,541
+11% +$35.2K ﹤0.01% 3979
2022
Q2
$385K Sell
68,399
-4,915
-7% -$39.8K ﹤0.01% 3748
2022
Q1
$864K Buy
73,314
+33,726
+85% +$408K ﹤0.01% 3404
2021
Q4
$750K Buy
39,588
+5,107
+15% +$111K ﹤0.01% 3555
2021
Q3
$712K Buy
+34,481
New +$741K ﹤0.01% 3600

Other funds holding TNYA

Bank of New York Mellon's TNYA Position: Q2 2026 in Review

Bank of New York Mellon held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 24,006 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4271.

Bank of New York Mellon first reported a position in TNYA in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.18M in Q2 2023. 57 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Bank of New York Mellon held 24,006 shares of Tenaya Therapeutics worth $17.7K as of Q2 2026.
  • Bank of New York Mellon left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4271 holding.
  • Bank of New York Mellon first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 17 quarters since.
  • Bank of New York Mellon's Tenaya Therapeutics position peaked at $1.18M in Q2 2023.
  • 57 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.